Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice

Cationic Solid Lipid Nanoparticles Loaded by Cystein Proteinase Genes as a Novel anti-Leishmaniasis DNA Vaccine Delivery System: Characterization and in vitro Evaluations

(2016) Delaram Doroud et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection

(2011) Delaram Doroud et al.   JOURNAL OF CONTROLLED RELEASE

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice

(2011) Delaram Doroud et al.   PLoS Neglected Tropical Diseases

DNA vaccines: a rational design against parasitic diseases

(2010) Joana A Carvalho et al.   Expert Review of Vaccines

Application of nanotechnologies for improved immune response against infectious diseases in the developing world

(2009) Michael Look et al.   ADVANCED DRUG DELIVERY REVIEWS

Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults

(2009) Mark Wallace et al.   MOLECULAR THERAPY

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis

(2009) Amir Mizbani et al.   VACCINE

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

(2008) J. Alvar et al.   CLINICAL MICROBIOLOGY REVIEWS

Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?

(2008) James Alexander et al.   MICROBES AND INFECTION

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS